Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zarnestra and Temozolomide in Recurrent Glioblastoma Multiforme
NCT00050986Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Dec 2002
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tipifarnib in glioblastoma multiforme (GBM), sponsored by University of Texas MD Anderson Cancer Center. Started Dec 2002; status: completed.
02
Drugs
tipifarnib
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00050986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00050986.